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Abstract—Pervasive computing applications bring together 
heterogeneous network-connected devices, services and resources 
to enable context-aware information integration. The increasing 
adoption of pervasive computing technology in the healthcare 
domain offers a healthcare model that delivers high quality 
service with fewer resources. In this paper, we briefly review the 
existing pervasive healthcare solutions and propose a novel 
provenance-aware system design that can enhance the 
performance of such solutions by means of including provenance 
capture functionality. We argue that our system architecture can 
improve quality of clinical data, efficiency of its collection, and its 
integrating ability with other data sources. To demonstrate our 
system and explain its provenance capacity, we use a clinical 
research example in which patient’s condition is closely 
monitored in order to assess the safety and efficacy of 
medications and treatments prescribed to him. 
Keywords— provenance; pervasive computing; PROV model; 
clinical research information system 
I.  INTRODUCTION 
Pervasive computing has become an active area of research 
in the last two decades since its introduction by Weiser in the 
early 1990s [1]. The current post-desktop computing facility 
exploits an increasing availability of small, embedded 
pervasive devices such as mobile phones, tablets and other 
portable personal devices to interlink the cyber world with 
physical reality and provide people with a more natural way to 
interact with information and services [13-15]. 
The constantly increasing healthcare cost and lack of 
clinical professionals have stimulated the adoption of pervasive 
computing technologies in the healthcare domain [2-7]. While 
pervasive healthcare [8] is still in its infancy, pervasive 
computing technologies usher a promising future in developing 
clinical applications, where patients’ condition must be 
monitored continuously. More specifically, modern low cost 
and low power mobile devices, portable wireless sensors and 
advanced communication technologies open the opportunity to 
construct a pervasive healthcare environment that surrounds an 
individual patient and enables gathering rich clinical data about 
him (e.g., patients’ behavior, physiological parameters, social 
dynamics, etc.) [2, 13]. The information collected by the 
devices can be further transited to a centralized clinical 
information system and become a part of the patient’s 
electronic healthcare record (EHR). 
However, one of the main challenges for such a system in 
healthcare is its ability to collect quality data traceable to 
individual devices’ context and usage and ensuring its validity 
for use, based on which critical decisions may be taken.  
Recent work in provenance research and the recent adoption of 
the provenance standard W3C PROV [17] provide a potential 
solution to address this challenge. The concept of provenance 
originates from the fine arts where it refers to the trusted, 
documented history of some work of art [22]. In computer 
systems, provenance is concerned with tracing the history of 
individual pieces of data. 
In this paper, we discuss how to capitalize on the existing 
engineering solutions and previous research efforts in pervasive 
computing in order to support data collection, validation, and 
integration processes in clinical applications. We propose 
generic provenance-aware pervasive system architecture that 
allows recording not only clinical facts about patients at the 
point of care (the current state of the art), but also relevant 
provenance information. We are particularly interested in 
provenance documentation of the data collection processes 
carried out by pervasive computing technologies, so as data 
sources could be verified and collected data could be easily and 
accurately integrated across various devices and heterogeneous 
environments. This would provide an advantage of ensuring 
accurate and comparable data, or at least a mechanism to alert 
of any mismatches or ambiguities across data sets (e.g. when 
translating age into data of birth). This is especially important 
in clinical applications, for example when selecting patients for 
participation in clinical trials. 
The paper is structured as follows. First, we discuss the 
advantages and challenges for pervasive computing in clinical 
applications that have motivated our work (Section II). We 
then present a state of the art synopsis on pervasive computing 
applications in the healthcare domain (Section III). Section IV 
outlines a clinical use case scenario, which we use to explain 
and demonstrate the proposed system design. Section V 
provides details on our solutions along with the discussion of 
the concept of provenance and its relevance and application to 
healthcare domain. With example graphs, we show how the 
provenance capacity of our solution can help to address the 
issues of traceability and validation when collecting patients’ 
electronic data. Section VI concludes the paper and discusses 
our future work. 
II. ADVANTAGES AND CHALLENGES FOR PERVASIVE 
COMPUTING IN CLINICAL APPLICATIONS 
Over the last decade, the pervasive adaptation of ICT has 
dramatically changed the healthcare landscape. The wide 
deployment of information system technology in healthcare 
centers has greatly improved the availability and accessibility 
of patients’ electronic records. The growing volume of 
healthcare information can help to improve the quality of 
healthcare service, allowing more extensive clinical research, 
and supporting rapid decision making in treatment of a disease 
and epidemic control [9].  
Clinical research includes patient-oriented research studies 
on human subjects. Several ICT application projects have 
emerged recently to facilitate acquisition and integration of 
medical information into clinical research [10, 11, 20, 21]. 
These projects aim to develop infrastructures for integrating 
distributed, and often heterogeneous, healthcare data sources 
for supporting clinical research. For instance, the Electronic 
Health Records for Clinical Research (EHR4CR) project [11, 
21] proposes an integrated platform that provides controlled 
and regulated access to hospital healthcare and research 
information systems, such as Electronic Health Records 
(EHRs) and Clinical Research Information Systems (CRISs). 
These may be distributed throughout numerous hospitals in 
many countries. A clinical researcher may then query the 
clinical research data for a multi-site study, for example to 
determine the number of patients who meet a set of criteria that 
would make them eligible subjects for a clinical trial. Such 
systems bring both financial (e.g. by reducing costs) and 
nonfinancial (e.g. by reducing selection times) benefits to those 
setting up and conducting clinical trials. 
Clinical research findings directly rely on complete and 
accurate data. Clinical research data capture is an extremely 
important part of a clinical research project. Traditionally, the 
process relies heavily on paper-based documentation which is 
time consuming and error prone. Over the last decades, paper 
case report forms (CRFs) at hospitals are increasingly replaced 
by computerized data capture, such as remote data capture 
(RDE) and electronic data capture (EDC) which are indeed 
early forms of pervasive computing applications. The adoption 
of these computerized data collection approaches were not 
initially motivated due to the lack of mobile hardware for data 
gathering [12]. With the advancement of mobile hardware and 
communication technologies however, pervasive computing 
becomes increasingly viable to replace the conventional data 
collection mechanisms in the healthcare domain. 
At the same time, such issues as data traceability and 
validation still remain among the challenges that discourage 
computerized data collection in clinical applications [12]. 
Although paper-based data collection is time consuming and 
error prone, paper data source documents can be kept for 
further validation and investigation. It is however difficult 
during computerized data collection in systems that lack of 
provenance capacity. Even if clinical data is stored in 
centralized information systems, questions regarding where, 
how, by whom and in what circumstances it has been collected 
would still have to be answered in a validation and 
investigation event. 
III. RELATED WORK 
A study on the state of the art in the relevant fields helps us 
to understand existing solutions and allows us to develop 
integrated solutions based on past research efforts without 
unnecessarily reinventing the wheel. In this synopsis, we 
review the recent efforts in developing pervasive computing 
applications in healthcare and clinical research domains. 
Pervasive computing in healthcare focuses on improving 
the quality of healthcare services, automating patient condition 
monitoring and diagnosis, as well as optimizing data 
acquisition, storage and management. Conti et al. [13] suggest 
that the adoption of sensor networks in patient care has been 
the most successful area in pervasive healthcare research so far, 
while Bardram [3] argues that pervasive healthcare 
technologies have been designed and developed to support 
continuous well-being, treatment, and care of people rather 
than focusing on technologies for acute treatment and care.  
The later paper summarizes the commonly recognized 
challenges in pervasive healthcare and presents a set of 
research themes in related scientific disciplines, such as 
monitoring and body sensor networks, pervasive assistive 
technologies, pervasive computing for hospitals, preventive 
and persuasive technologies. The author advocates that 
information management in the healthcare environment is 
becoming increasingly decentralized. Pervasive computing can 
provide technologies to support patient self-care, allow 
clinicians to reach out to home-based patients, enable 
continuous monitoring for diagnosis, early detection, treatment 
of diseases, and optimize information acquisition, storage, 
integration, processing, and management. This paper presents 
two prototypical examples to illustrate the challenges in 
pervasive healthcare, discusses how pervasive computing 
technology can be designed to meet these challenges and 
recommends a ”clinical proof-of-concept” approach for 
pervasive healthcare research. 
A study conducted by Orwat et al. [2] also suggests that 
pervasive computing is increasingly influencing healthcare and 
medicine. The authors conclude that pervasive computing is 
loosely associated with many future technologies and its 
definition has not been clearly defined in the current literature. 
Their paper reviews recent pervasive computing systems in 
healthcare and highlights experiences in the development of 
pervasive computing systems. Their study has explored 
published research in pervasive computing and conducted a 
search with scientific databases and journals for the period of 
2002 to 2006. The search results have revealed a great diversity 
of the pervasive computing systems in healthcare field. In total, 
69 articles have been identified, in which the development of a 
pervasive computing system is reported. The identified articles 
describe 67 different systems, 84% of them are in their 
prototype or pilot stages, 9% have passed clinical trials, and 
7% have been in regular operation. The majority of the systems 
(48%) have been developed for analytical and diagnostic 
support. 
Pervasive computing is inherently context-aware. Black et 
al. [5] have envisioned a “smart hospital” environment in 
which context-aware applications are extensively adopted to 
assist in clinical care. The paper describes a scenario where 
context middleware and pervasive computing technologies are 
used together for building an integrated enterprise environment 
in which wireless devices and wearable sensors are deployed 
around patients and their carers to collect contextual 
information and monitor their locations, conditions and 
behavior. An imaginative use case has been used in this paper 
to demonstrate how context-aware applications can help 
improve healthcare service delivery, nurse triage and 
information management. The paper reports a prototype of the 
enterprise smart space described in the use case and identifies 
requirements and challenges in developing context-aware 
pervasive healthcare systems. Similar work is described by 
Moran et al. [7], who report some empirical information about 
the movement pattern of hospital workers and how they 
interact with information while moving. The paper discusses 
how their study results can help in developing pervasive 
computing technologies for healthcare. 
Bardram [6] describes a context-aware pervasive 
computing application for medical work in hospitals and 
elaborates on a context-awareness infrastructure in a hospital 
that supports various clinical applications. The paper uses some 
example applications to illustrate the conceived ideas. The use 
case scenarios demonstrate what context-awareness can mean 
in a healthcare environment, and explain how to design and 
develop a context-aware application to deal with the 
challenges. Finally, the paper concludes some key design 
principles for constructing a context-aware infrastructure in 
hospitals and developing context-aware clinical applications. 
Floerkemeier et al. [4] propose the development of smart 
medication device pack. The device is equipped with sensors to 
detect the consumption of pills and can update information to 
the central information system via mobile network. The authors 
explain that the smart device pack can be used for monitoring 
the patient’s compliance in clinical trials. The automatically 
collected information can assist the researchers to assess 
outcomes and determine whether adverse reactions or 
inadequate therapeutic responses are a result of the drug or a 
result of the patient not taking the medication. The compliance 
data can also be used for improving the management of clinical 
trials. 
Mihailidis et al. [8] present a pervasive computing 
application for supporting clinical trials. The authors describe a 
system that can automatically remind nurses to perform 
scheduled tasks for a clinical trial. The system uses a range of 
smart devices to accurately acquire vital signs of a patient and 
transfer the data to a centralized information system. The 
authors argue that the system can help eliminate possible 
measurement and data entry errors that are commonly seen in 
clinical trials, improving clinical trial management and 
significantly reducing the amount of time spending on data 
entry compared to the conventional practice. 
Finally, remote patient monitoring is becoming increasingly 
plausible in healthcare. The advancement of sensor and 
wireless mobile device technologies has enabled the pervasive 
healthcare approach for remote acquirement of information 
about a patient’s clinical parameters and activity patterns, with 
some smart devices being able to automatically conduct remote 
medical analysis for risk prevention. For example, Chowdhury 
et al. [16] present a mobile phone-based system, called 
MediAlly, that has the ability to capture medical data streams 
from a remote subject. The system is context-aware, which in 
this case means that it can collect, store and process the 
medical data streams based on user-specified context rules. As 
an example, authors say that a doctor would find it useful to 
know if a data stream corresponding to "30 minutes of elevated 
heart rate", recorded a month ago, occurred while the subject 
was exercising at a health club or seated at his home. The 
current setup of MediAlly has only been tested in a laboratory 
environment and the question of the accuracy of context 
inference for specific application needs still remains open. 
IV. A CLINICAL TRIAL SCENARIO 
The review of the existing pervasive healthcare solutions 
suggests that most are lacking provenance capture functionality 
to specifically address the issues of data quality, integrity, and 
validation. The questions of how data has been collected, 
transformed and verified are crucial in the healthcare domain, 
especially when integrating multiple data sources (e.g. from 
several points of care) or taking same measurements in 
different settings (e.g. blood pressure of a standing or lying 
patient). For example, one clinical system can store patient’s 
age, while another – his date of birth. Date format may also be 
different (e.g. including or not the time along with the date). 
Such variations could lead to fact distortion, which may be 
critical when selecting patients for participation in clinical 
trials; incorrect inclusion or exclusion of patients may seriously 
affect research findings.  
Below, we propose a provenance-aware pervasive 
computing system that is designed to address the named issues.  
To assist us in demonstrating our solution (presented in the 
following section), we provide a running example that 
describes the data collection process in a clinical trial. This 
example illustrates how advanced pervasive computing 
technologies can be used for optimizing collection of clinical 
data from study subjects and improving the quality of the data. 
In our scenario, a phase-I clinical trial is conducted for 
testing the safety of a new drug. The study is carried out in a 
smart hospital, in which a pervasive healthcare environment is 
implemented with methods similar to those we reviewed in the 
previous section. In the hospital, all patients wear Radio 
Frequency Identification (RFID) tags. The patient rooms are 
instrumented with portable vital sign monitors that can 
communicate to a central data server via wired or wireless 
networks. Site professionals are equipped with wireless PDAs 
that can download and upload data from and to centralized 
hospital information systems. 
 The study involves a number of patients. Each patient is 
assigned to a nurse. The study protocol specifies the dosage 
and data collection procedures. The procedure can be 
downloaded to a portable PDA which runs clinical trial 
application software to instruct the nurse how to perform the 
trial and collect data. The nurse needs to follow the procedures 
to distribute the drugs to her patients, and take blood samples 
and measure the patient’s vital signs (blood pressure and body 
temperature). Finally, the nurse needs to complete case report 
forms (CRFs) and enter the data into the central data system. 
  
  
Fig. 1. A smart hospital with a pervasive healthcare environment. 
 
 
V. THE PROPOSED SYSTEM 
 In the following sections, we explain our generic, scalable, 
pervasive computing system architecture and a provenance-
based approach to addressing the data collection, traceability 
and validation challenges in clinical applications. The system, 
as shown in Figure 1, can be seamlessly integrated with 
existing pervasive healthcare infrastructure to achieve 
automated clinical trial management and improve the quality 
and speed of clinical research data collection. In particular, the 
system employs provenance capacity in each of its subsystems, 
including the smart devices, to ensure the traceability of data 
collection. Figure 2 illustrates the basic functionality and 
capacities of the subsystems. It is worth noting that while it is 
plausible to employ the provenance recording capacity in all of 
the subsystems involved in the system, some smart devices 
may not have sufficient capacity to support such functionality 
(this issue is not addressed in this paper). 
 
A. System architecture 
As can be seen from Figures 1 and 2, our system consists of 
the following components. 
Clinical Trial Management System (CTMS): The CTMS is 
a centralized information system that manages the clinical trial 
projects. It implements a web-based interface which allows 
authenticated users to access project information. The access 
control is role-based, so that users only have access to the 
information permitted by their roles. The CTMS is also a task 
scheduling system. A task schedule is implemented from the 
study protocol of a project. It includes a series of procedures 
which instruct a nurse on when to distribute doses to her patient 
and take blood samples and measure the blood pressure and 
cholesterol of the patient.  
 
Fig. 2. The proposed system architecture 
 
 
Central Resource Management System (CRMS): The 
CRMS is a central resource registry that manages the 
information about the pervasive devices. A pervasive device 
has to be registered before it can be used. Once registered, the 
device becomes a part of the pervasive healthcare infrastructure 
of the hospital. When the device is in use, it also needs to 
register the context information about its usage. For instance, 
when a nurse uses a wireless PDA, her login information will 
be sent to the CRMS, so the device is bound to the nurse until 
she logs out or someone else logs in on the device. The CRMS 
is also a communication gateway between the pervasive 
resources and other systems. 
Clinical Information Systems (CISs): A CIS is a collection 
or integration of healthcare information systems of a hospital. 
A good example is the EHR system which is a centralized 
patient healthcare data repository. A hospital may have a 
number of heterogeneous CISs, therefore interoperability of 
various data sources has to be ensured (the issue we address 
elsewhere but not in this paper). Typically, data acquired from 
the CISs has to be anonymous when being integrated into 
clinical research data set. 
Pervasive devices: This category includes the 
heterogeneous smart devices that form the pervasive healthcare 
infrastructure of the hospital. Examples include wireless PDAs 
which physicians and nurses carry with them and network-
enabled blood pressure monitors being deployed in patients’ 
rooms. 
B. Usage scenario 
Following our running example introduced in section IV, a 
specific usage scenario can be described as follows (Sarah is 
the name of the nurse). 
1) Clinical trial schedule: When a scheduled task is due, the 
CTMS sends a reminder to Sarah’s PDA via the CRMS. When 
Sarah becomes available, she logs into the CTMS to 
acknowledge the reminder and proceed to the patient room to 
perform the tasks. 
 Fig. 3. The provenance of the baseline CRF in the PDA. 
 
Fig. 4. The provenance of the final CRF by the CTMS.
2) Data collection: When Sarah logs in to the CTMS on her 
PDA, the procedure is displayed on the device. She needs to 
follow the procedure, tick each instruction upon completion, 
and enter data if required. The procedures include: 
• First, Sarah needs to read the patient’s RFID tag with her 
PDA to identify the patient. The software sends the 
information to the CTMS which in turn invokes the EHR 
to verify the patient. 
• Once the patient is verified, Sarah needs to prepare the 
instrumentation, i.e. the blood pressure meter and the 
blood cholesterol meter in our case. These smart devices 
can also read the RFID tag the patient wears. So the 
measurements will be sent to the CISs and the CTMS with 
the patient’s unique identifier. Sarah needs to verify the 
patient’s ID against the one displayed on her PDA. 
• When the patient is verified, the nurse needs to instruct the 
patient to take the doses as described. When Sarah ticks to 
indicate the completion of the task, the software logs the 
time. 
• The procedure instructs the nurse to take the clinical 
measurements of the patient after ten minutes. Sarah needs 
to verify the clinical measures displayed on the meters and 
enter them on her PDA. The meters also automatically 
send the measurements to the EHR once the readings are 
confirmed by Sarah.  
• When all tasks in the procedure are ticked, the PDA will 
automatically integrate the data, and display a CRF on the 
screen [7]. Sarah needs to check the form, and if 
everything is correct, she clicks the “Submit” button, upon 
which the PDA will send the form to the CTMS. 
• Finally, Sarah logs out from the CTMS, and moves to her 
next patient. 
Once the CTMS receives the baseline CRF from Sarah’s 
PDA, it automatically verifies and integrates the data received 
from the smart meters to generate the final CRF. The clinical 
data set and the report can then be inspected by the clinical 
investigator for compliance checks and further validation. In 
certain systems, the clinical researcher from the trial sponsor 
side may be allowed access to the CTMS under appropriate 
security and privacy arrangements. 
C. Provenance awareness 
Traditional validation of clinical data involved someone 
manually comparing the paper document with the 
computerized data. Validation is one inherent issue in 
computerized data collection. This issue is especially 
prominent in a pervasive healthcare environment where data 
collection and integration are computerized. In the previous 
section, we discussed an architectural solution and its usage 
scenario to demonstrate how to eliminate errors in data 
collection in an appropriately designed clinical application. 
However, manual validation processes with paper-based source 
documents are still considered the gold standard by many. We 
propose a provenance-based approach to addressing the data 
validation challenges in clinical research projects in a pervasive 
healthcare environment. We argue that the provenance data of 
the clinical data can sufficiently replace the paper-based data 
validation approach in many circumstances. In addition, it will 
remarkable improve the traceability and auditability of the data 
collection process.  
We use the emerging W3C PROV [17] standard to 
illustrate the form of provenance documentation captured in the 
data collection processes during a clinical trial. We provide 
examples of provenance graphs of the scenario described above 
to illustrate the provenance data available to answer the 
following validation questions: 
1) How was the data collected? The question can be further 
decomposed into several more specific questions such as who 
collected what data, what procedure was followed during the 
data collection, and so on. We expect to use the provenance of 
the final CRF to ensure the quality of the data. 
2) How was the data integrated? During the data collection 
process, datasets are transformed and integrated into a 
structured dataset. These integration processes are largely 
automated by software. We want to use the provenance 
information of the transformation and integration processes to 
inspect the correctness of the system functions. 
3) How was the data verified? As we discussed in the 
previous section, data is repeatedly verified by the nurse in the 
patient room and the CTMS. We want to use the provenance 
information of these validation processes to affirm the 
validation.  
Provenance documentation: The W3C PROV [17] 
specification proposes a collection of interoperability solutions, 
such as the PROV data model, the PROV ontology, and 
provenance accessing and querying mechanisms. During the 
data collection, processes involved need to be recorded in a 
pro-actively defined template to facilitate provenance data 
integration. 
The systems involved in the data collection process, such as 
the PDA, CTMS, and the CISs, employ provenance recording 
engines to capture provenance information regarding the data 
the systems handle and the processes they enact. During the 
execution of the processes, provenance information such as the 
input, output and execution time are recorded to generate 
provenance data. The provenance data from the systems can be 
integrated to generate a provenance graph, as shown in Figures 
3 and 4, which can then be visualized for validating the final 
CRF and the entire data collection process. 
In the graphs (Figures 3 and 4), the visual notation 
employed by PROV is followed. An oval denotes an entity, 
which is a digital or physical thing, in this case used for data 
items or devices. A rectangle denotes an activity, 
corresponding to the execution of an action or process in an 
individual instance. A pentagon (envelope-shape) is an agent 
denoting something or someone who has responsibility for an 
activity taking place, commonly referring to a person or 
organization. Some attributes of activities are given, 
specifically timestamps of when they started and ended. As 
indicated by arrows, entities and activities are causally related, 
so the graph states where an activity used an entity in its 
execution, where an entity was generated by the execution of 
an activity, where one entity was derived from another, or one 
activity received data or was triggered by (‘was informed by’) 
another. 
The PROV specifications [17] are application-agnostic. The 
PROV Ontology (PROV-O) specification defines a collection 
of vocabularies in OWL2 Web Ontology Language to encode 
the PROV Data Model (PROV-DM). Domain specific profiles 
can be created to extend the PROV-O to facilitate interoperable 
provenance modeling in a particular domain or an application. 
In our system, we define a Pervasive Clinical Application 
(PCA) PROV profile to ensure the interoperability of the 
provenance capacities in systems and devices forming the 
pervasive healthcare infrastructure. We use the namespace 
prefix pct to denote the terms defined in the profile. Those 
vocabularies are used in combination with the PROV-O 
vocabularies, with the namespace prefix prov, to annotate the 
relations between entities, activities and agents. The PCA 
profile specific annotation vocabularies are defined in Table I. 
TABLE I.  PCA (PCT:) ANNOTATION VOCABULARIES 
SentTo annotates a message or a document was sent to 
a remote system or device. 
SavedTo annotates a piece of data is saved into a local data repository or a database system. 
wasReceivedFrom annotates the source of a data or document. 
 
During the data collection process described in the 
scenario, the provenance engines in both Sarah’s PDA and the 
CTMS record the activities taken place on the system (device). 
Figure 3 presents the provenance graph produced by Sarah’s 
PDA. The graph describes how the baseline CRF was 
produced. It shows the activities happened in the PDA, starting 
from Sarah’s login, until the baseline CRF was generated and 
being sent to the CTMS. Figure 4 presents the provenance 
graph produced in the CTMS to reflect the activities happened 
in the system during the data collection process. These 
activities include the communication and data exchange 
processes between the CTMS and the smart devices, i.e. the 
PDA and the smart meters. 
These graphs share a common node, the baseline CRF 
(pct:baselineCRF), and therefore the two can be readily 
integrated into a single graph providing a richer history of the 
data collection than either individual device could provide. 
Furthermore, the provenance graphs produced by the other 
systems involved in the process can be queried to expand the 
integrated provenance graph.  
In general, provenance graphs from the provenance data 
can be generated for different users and different purposes with 
different levels of information granularity.  
Provenance-based validation: So far, we have discussed 
how to use provenance documentation to record the data 
collection processes and generate the provenance graphs. The 
provenance graph can trustfully reveal the collection of 
processes and resources involved in generating a result, i.e. the 
baseline CRF and the final CRF in our examples. The 
processes are not only recorded, but also annotated, so the 
provenance data and graphs can be used for examining the 
behaviors of the systems and devices, as well as the 
responsibilities of personnel involved in the data collection 
process. With the rapid advancement of ICT and pervasive 
computing technologies, it is foreseeable that the data 
collection and integration processes in clinical applications will 
become increasingly computerized. The scale and complexity 
of such applications will easily exceed what we discussed in 
the example scenario. However, the scalability of our 
provenance-based solution will ensure the efficacy and 
feasibility of our approach. In fact, as the complexity of the 
application increases, the benefits that our provenance-based 
validation solution can bring will make our approach even 
more prominent and appealing. 
VI. CONCLUSION 
In summary, the paper proposes provenance-aware system 
architecture for pervasive healthcare computing applications. 
Our generic and scalable solution allows a hospital to integrate 
its pervasive healthcare capacities and resources in order to 
improve the efficiency and reduce the cost of clinical trials. 
The pervasive computing-powered computerized data 
collection approach can significantly improve the quality and 
eliminate data entry errors in collection of clinical data. Our 
provenance-based approach demonstrates the feasibility of 
using provenance documentation and provenance graphs for 
validation of clinical data. 
Our research is still in an early stage. We intend to apply a 
prototype of the system and the provenance tools proposed in 
this paper to real-world applications such as the EHR4CR 
project [11]. We also want to further investigate the challenges 
that exist in developing provenance-aware pervasive solutions 
for clinical applications, such as: (i) how to ensure the 
provenance information is accurate in a pervasive environment 
where many devices may fail; (ii) how to secure provenance 
information so that it is not corrupted by illegitimate users or 
innocent mistakes; (iii) how to efficiently store all of the 
provenance information in a way that scales and yet is 
accessible to all pervasive devices. 
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